Navigation Links
Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction
Date:11/1/2007

ds "may," "might," "will," "should," "estimate," "project," "plan," "anticipate," "expect," "intend," "outlook," "believe" and other similar expressions are intended to identify forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates. These forward-looking statements are based on estimates and assumptions by our management that, although we believe to be reasonable, are inherently uncertain and subject to a number of risks and uncertainties.

The following represent some, but not necessarily all, of the factors that could cause actual results to differ from historical results or those anticipated or predicted by our forward-looking statements: our substantial, indebtedness; competitive factors in the industry in which we operate; our ability to protect our intellectual property; a delay in qualifying our manufacturing facility to produce our products or production or regulatory problems with either third party manufacturers upon whom we rely for some of our products or our own manufacturing facility; pricing pressures from reimbursement policies of private managed care organizations and other third party payors, government sponsored health systems, the continued consolidation of the distribution network through which we sell our products, including wholesale drug distributors and the growth of large retail drug store chains; the loss of key senior management or scientific staff; an increase in litigation, including product liability claims and patent litigation; government regulation affecting the development, manufacture, marketing and sale of pharmaceutical products, including our ability and the ability of companies with whom we do business to obtain necessary regulatory approvals; our ability to successfully complete the implementation of a company-wide enterprise resource planning system without disrupting our business; our ability to manage the growth of our busi
'/>"/>

SOURCE Warner Chilcott Company, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Collaborations planned between British Organization and Indian health care industry
2. More collaborations and strengthening of India’s AIDS control body require
3. Crusade Against Cancer: Collaborations On The Anvil
4. Mayo Clinic and Indian Health Service Form Clinical Practice Collaboration
5. International Collaboration Takes Aim at Rabies
6. A Collaboration to Find New Tools to Fight Leukemia
7. British Medical Association Plans Collaboration With India
8. British Medical Association Plans Collaboration With India
9. LondonMet Keen on Widening Research Collaborations With India
10. Topical Quinolone effective in controlling eardrum perforations
11. Short-Term Topical Corticosteroid May Offer Relief for Certain Type of Psoriasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... December 26, 2014 “Many people become ... personal injury claim issues and phone calls with insurance ... an article featuring their free eBook on pedestrian ... eBook on pedestrian and bicycle auto accident claims assures ... fully capable of professionally handling their case while they ...
(Date:12/26/2014)... December 26, 2014 Parker & ... the best in heating, cooling and plumbing contractor ... hour emergency services in 2014 with regard to ... that Arizona is known for its incredibly hot ... understands the intricacies and details of a wide ...
(Date:12/25/2014)... The report “Nintedanib (Colorectal Cancer) ... on the current treatment landscape, unmet needs, current ... market. Stivarga is a drug which is used ... Boehringer Ingelheim is developing nintedanib (BIBF-1120), an orally ... CRC in the US, Europe, and Japan. The ...
(Date:12/25/2014)... December 26, 2014 Recently, iFitDress.com, the popular ... women, has announced its new selection of black one-shoulder ... on sale now; they are available at discounted prices, up ... “The promotion will last for three weeks only. You know, ... Those who are interested in our new items can visit ...
(Date:12/25/2014)... 2014 BambooFlooringChina.com sells many bamboo products ... flooring. Today, the company announces big discounts on ... and colors. , BambooFlooringChina.com is the world’s leader in ... is valid until Jan. 20, 2015. , The bamboo ... with a natural thread. All the bamboo strips for ...
Breaking Medicine News(10 mins):Health News:Guide to Handling Pedestrian and Bicycle Accidents Released By The Jones Firm, Featured in Recent Article 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
... By Jenifer Goodwin HealthDay Reporter , TUESDAY, ... be reduced if operating room staff borrowed team-building procedures ... A program that trained operating room workers to ... and to review what went right or wrong after ...
... By Jenifer Goodwin HealthDay Reporter , TUESDAY, ... before heart surgery suffered fewer heart attacks, stroke and ... had better survival rates, two new studies find. ... bypass, valve or other scheduled cardiac surgeries. Of those, ...
... 19, 2010A rare and deadly form of breast cancer ... is the focus of a new report from leading ... an unrecognized and misunderstood form of breast cancer. It ... has lower overall survival compared to other breast cancers. ...
... a child or a dog play is not a foreign sight. ... Apparently, they play, too. In fact, according to Gordon Burghardt, ... -- not just dogs, cats, and monkeys -- need a little ... juvenile reptiles for many years and never saw anything that I ...
... Reporter , MONDAY, Oct. 18 (HealthDay News) -- ... medical mistakes, ranging from an operation on the wrong ... a new study finds. To try to curb ... 2004 introduced a universal protocol for all hospitals, ambulatory ...
... and quality of life for older people, but is also ... The research will be presented today,s at the Scientific Program ... East-Africa Council of Ophthalmology (MEACO) Joint Meeting. Cataract surgery not ... but is also apparently a way to reduce the number ...
Cached Medicine News:Health News:Lessons From Flight Crews Can Help Surgical Teams Work Better 2Health News:Lessons From Flight Crews Can Help Surgical Teams Work Better 3Health News:Aspirin, Statins May Reduce Problems After Heart Surgery 2Health News:Aspirin, Statins May Reduce Problems After Heart Surgery 3Health News:Inflammatory breast cancer focus of new report 2Health News:UT professor defines play, discovers even turtles need recess 2Health News:Surgery on Wrong Patients, Surgical Sites Persists, Study Finds 2Health News:Surgery on Wrong Patients, Surgical Sites Persists, Study Finds 3Health News:Surgery on Wrong Patients, Surgical Sites Persists, Study Finds 4Health News:Cataract surgery saves lives, dollars by reducing auto crashes 2
(Date:12/24/2014)... 2014   Synageva BioPharma Corp. (NASDAQ: ... therapeutic products for rare disorders, today announced validation ... Marketing Authorization Application (MAA) for sebelipase alfa for ... request for accelerated assessment, which has the potential ... The MAA, and the Biologics License ...
(Date:12/24/2014)... CHENGDU, China , Dec. 23, 2014 /PRNewswire/ ... a pharmaceutical company that specializes in patented biopharmaceutical, ... active pharmaceutical ingredients (API) today announced that the ... for its Good Manufacturing Practice (GMP) certificate of ... & Drug Administration,s (CFDA). The public notice period ...
(Date:12/22/2014)... 22, 2014  CytoSorbents Corporation (OTCQB:CTSOD), a critical ... purification technology to help fight deadly inflammation in ... worldwide, today announced the appointment of Dr. ... its Senior Vice President of Clinical Development, effective ... Di Russo is an accomplished pediatric cardiothoracic ...
Breaking Medicine Technology:Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5
... VIEW, Calif. , July 20 Alexza Pharmaceuticals, Inc. (Nasdaq: ... fiscal quarter ended June 30, 2010 , on Monday, July ... Company will host an investor conference call and live webcast to provide ... Monday, July 26 at 5:00 p.m. Eastern Time ...
... , July 20 Sysmex, a global ... technology, today announced the addition of the CellaVision® DM1200 ... offering.  The DM1200 enables Sysmex America to meet the ... both the quality of results and the productivity of ...
Cached Medicine Technology:Alexza to Announce 2010 Second Quarter Financial Results on Monday, July 26, 2010 2Alexza to Announce 2010 Second Quarter Financial Results on Monday, July 26, 2010 3Alexza to Announce 2010 Second Quarter Financial Results on Monday, July 26, 2010 4Sysmex America Begins Distribution of CellaVision® DM1200 2Sysmex America Begins Distribution of CellaVision® DM1200 3
... Size: 5.0 x 2.5 x 80 mm. Half ... by Harvey A. Lincoff, M.D. has been modified ... design. The material is a closed cell sponge ... with rounded edges to minimize scleral intrusion. These ...
For use under curved implants. Indications: When additional buckling is required in the meridional direction. Overall length: 15.0 mm....
For use with E5381 600 Circling Band (40 style)....
Ungrooved permanent silicone strip. Indications: For trapdoor procedure. Overall length: 125 mm, 4.9 inches....
Medicine Products: